EBS
Emergent BioSolutions Inc.
8.28
200 x 8.20
400 x 8.47
bid
ask
-
0.10
1.19%
300 @ 04:00 PM
8.40 +0.12 (1.45%)
Ytd-33.01%
1y25.45%
8.27
day range
8.63
5.62
52 week range
14.06
Open8.31Prev Close8.38Low8.27High8.63Mkt Cap427.22M
Vol430.98KAvg Vol809.80KEPS-0.19P/EN/AForward P/E2.73
Beta1.57Short Ratio4.54Inst. Own60.02%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning04-3050-d Avg8.37200-d Avg9.721yr Est12.00

EBS News

benzinga.com
Emergent BioSolutions Secures $52.7M U.S. Government Contract Modification For ACAM2000 Smallpox And

Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued

Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
globenewswire.com
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM20

GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announce

benzinga.com
FDA Broadens Access to Over-The-Counter Naloxone Nasal Spray for Opioid Overdose

https://www.fda.gov/news-events/press-announcements/fda-broadens-access-over-counter-naloxone-nasal-

benzinga.com
Emergent BioSolutions Wins $64.5M U.S. HHS Contract Modification To Supply Botulism Antitoxin BAT Un

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has been awarded a contract modification va

benzinga.com
U.S. CDC Says Will Enhance Screening And Monitoring Of Travelers Arriving From Areas Affected By Ebo

https://www.cdc.gov/ebola/situation-summary/index.html

benzinga.com
Emergent BioSolutions Announces Saudi Approval For ACAM2000, Its Smallpox and Mpox Vaccine

Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food a

Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript
benzinga.com
Emergent BioSolutions Q1 2026 Earnings Call: Complete Transcript

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Emergent BioSolutions Sees Q2 Sales $170.000M-$185.000M vs $186.000M Est

Emergent BioSolutions (NYSE:EBS) sees Q2 sales of $170.000 million-$185.000 million vs $186.000 mill

benzinga.com
Emergent BioSolutions Affirms FY2026 Sales Guidance of $720.000M-$760.000M vs $735.000M Est

Emergent BioSolutions (NYSE:EBS) affirms FY2026 sales outlook from $720.000 million-$760.000 million

benzinga.com
Emergent BioSolutions Q1 Adj. EPS $0.21 Beats $(0.25) Estimate, Sales $156.100M Beat $145.000M Estim

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.21 per share which beat the analy

benzinga.com
Emergent BioSolutions Receives Singapore's Health Sciences Authority Approval For Expanded Indicatio

Emergent BioSolutions Inc. (NYSE:EBS) today announced that Singapore's Health Sciences Authority

Earnings Scheduled For April 30, 2026
benzinga.com
Earnings Scheduled For April 30, 2026

benzinga.com
Emergent BioSolutions Signs Multi-Year, ~$50M Agreement With SAB Biotherapeutics For Development And

The executed agreement is valued at approximately $50 million, of which $36 million is contingent on

benzinga.com
Emergent BioSolutions Signs ~$34.5M Agreement With Substipharm Biologics Over Drug Substance Product

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has entered into an agreement with Substiph

benzinga.com
Emergent BioSolutions Collaborates With B.C. Provincial Health Services Authority To Provide Nasal S

Emergent BioSolutions (NYSE:EBS) announced that it has partnered with the B.C. Provincial Health Ser

benzinga.com
Emergent BioSolutions Secures ~$54M Contract To Provide CNJ-016 Vaccinia Immune Globulin Intravenous

Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at app

benzinga.com
HC Wainwright & Co. Maintains Buy on Emergent BioSolutions, Lowers Price Target to $12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Emergent BioSolutions (NYSE:EBS) wit

Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
benzinga.com
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving

Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results
benzinga.com
Nasdaq Down Over 1%; Dell Shares Jump After Q4 Results

U.S. stocks down mid-trading, Nasdaq falls 1%. Dow down 1.40%, S&P 500 falls 0.74%. Dell shares

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

Dow Dips Over 600 Points; US Producer Prices Increase In January
benzinga.com
Dow Dips Over 600 Points; US Producer Prices Increase In January

US stocks traded lower, Dow down 600 points. Nasdaq and S&P also fell. Consumer staples up, tech

12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premark

Earnings Summary: Emergent BioSolutions Q4
benzinga.com
Earnings Summary: Emergent BioSolutions Q4

benzinga.com
Emergent BioSolutions Sees FY2026 Sales $720.000M-$760.000M vs $1.155B Est

Emergent BioSolutions (NYSE:EBS) sees FY2026 sales of $720.000 million-$760.000 million vs $1.155 bi

benzinga.com
Emergent BioSolutions Q4 Adj. EPS $(0.43) Misses $0.11 Estimate, Sales $148.700M Miss $217.500M Esti

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.43) per share which missed the ana

Earnings Scheduled For February 26, 2026
benzinga.com
Earnings Scheduled For February 26, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access
benzinga.com
Emergent BioSolutions Wins FDA Approval For New Narcan Multipacks To Expand Overdose Access

Emergent BioSolutions Inc. (EBS) stock rose Friday as FDA approved new multipack configurations of o

benzinga.com
Emergent BioSolutions Obtains FDA Approval For Its Supplemental New Drug Application For New Multipa

Today, Emergent BioSolutions (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) h

Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading
benzinga.com
Dirty Vaccines, Clean Cash: Emergent Ex-CEO Sued For Insider Trading

New York Attorney General sued the former CEO of Emergent BioSolutions, Robert G. Kramer, for inside

benzinga.com
Attorney General James Sues Former CEO Of Emergent BioSolutions For Insider Trading

https://ag.ny.gov/press-release/2026/attorney-general-james-sues-former-ceo-emergent-biosolutions-in

benzinga.com
FDA Approves Emergent BioSolutions' sNDA For OTC NARCAN Nasal Spray To Be Packaged In New Carrying C

Since the U.S. prescription launch of NARCAN® Nasal Spray in 2016, the medicine has been trusted as

benzinga.com
Emergent BioSolutions Made Voluntary Prepayment Of $100M Under Its Outstanding Term Loan Facility In

"This significant milestone reflects strong progress in improving our overall financial/cash pos

benzinga.com
Emergent BioSolutions Bags Delivery Order Valued At Up To $21.5M From U.S. Department Of War To Supp

Today Emergent BioSolutions (NYSE:EBS) announced it has received a delivery order valued at up to $2

benzinga.com
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) wi

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday
benzinga.com
Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
HC Wainwright & Co. Reiterates Buy on Emergent BioSolutions, Maintains $15 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) wi

benzinga.com
Emergent BioSolutions Secures $30M BARDA Contract To Supply CYFENDUS Anthrax Vaccine By March 2026

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has received a $30 million contract modific

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

benzinga.com
Earnings Scheduled For August 6, 2025

benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session

benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session